30405366|t|Cannabis Therapeutics and the Future of Neurology.
30405366|a|Neurological therapeutics have been hampered by its inability to advance beyond symptomatic treatment of neurodegenerative disorders into the realm of actual palliation, arrest or reversal of the attendant pathological processes. While cannabis-based medicines have demonstrated safety, efficacy and consistency sufficient for regulatory approval in spasticity in multiple sclerosis (MS), and in Dravet and Lennox-Gastaut Syndromes (LGS), many therapeutic challenges remain. This review will examine the intriguing promise that recent discoveries regarding cannabis-based medicines offer to neurological therapeutics by incorporating the neutral phytocannabinoids tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors, tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA), and cannabis terpenoids in the putative treatment of five syndromes, currently labeled recalcitrant to therapeutic success, and wherein improved pharmacological intervention is required: intractable epilepsy, brain tumors, Parkinson disease (PD), Alzheimer disease (AD) and traumatic brain injury (TBI)/chronic traumatic encephalopathy (CTE). Current basic science and clinical investigations support the safety and efficacy of such interventions in treatment of these currently intractable conditions, that in some cases share pathological processes, and the plausibility of interventions that harness endocannabinoid mechanisms, whether mediated via direct activity on CB1 and CB2 (tetrahydrocannabinol, THC, caryophyllene), peroxisome proliferator-activated receptor-gamma (PPARgamma; THCA), 5-HT1A (CBD, CBDA) or even nutritional approaches utilizing prebiotics and probiotics. The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and portend to revolutionize neurological treatment into a new reality of effective interventional and even preventative treatment.
30405366	156	183	neurodegenerative disorders	Disease	MESH:D019636
30405366	401	411	spasticity	Disease	MESH:D009128
30405366	415	433	multiple sclerosis	Disease	MESH:D009103
30405366	435	437	MS	Disease	MESH:D009103
30405366	447	482	Dravet and Lennox-Gastaut Syndromes	Disease	MESH:D065768
30405366	484	487	LGS	Disease	MESH:D065768
30405366	697	714	phytocannabinoids	Chemical	-
30405366	715	735	tetrahydrocannabinol	Chemical	MESH:D013759
30405366	737	740	THC	Chemical	MESH:D013759
30405366	743	754	cannabidiol	Chemical	MESH:D002185
30405366	756	759	CBD	Chemical	MESH:D002185
30405366	787	814	tetrahydrocannabinolic acid	Chemical	-
30405366	816	820	THCA	Chemical	-
30405366	826	844	cannabidiolic acid	Chemical	MESH:C006884
30405366	846	850	CBDA	Chemical	MESH:C006884
30405366	866	876	terpenoids	Chemical	MESH:D013729
30405366	1052	1060	epilepsy	Disease	MESH:D004827
30405366	1062	1074	brain tumors	Disease	MESH:D001932
30405366	1076	1093	Parkinson disease	Disease	MESH:D010300
30405366	1095	1097	PD	Disease	MESH:D010300
30405366	1100	1117	Alzheimer disease	Disease	MESH:D000544
30405366	1119	1121	AD	Disease	MESH:D000544
30405366	1127	1149	traumatic brain injury	Disease	MESH:D000070642
30405366	1151	1154	TBI	Disease	MESH:D000070642
30405366	1156	1188	chronic traumatic encephalopathy	Disease	MESH:D000070627
30405366	1190	1193	CTE	Disease	MESH:D000070627
30405366	1456	1471	endocannabinoid	Chemical	MESH:D063388
30405366	1524	1527	CB1	Gene	1268
30405366	1532	1535	CB2	Gene	1269
30405366	1537	1557	tetrahydrocannabinol	Chemical	MESH:D013759
30405366	1559	1562	THC	Chemical	MESH:D013759
30405366	1564	1577	caryophyllene	Chemical	MESH:C024714
30405366	1580	1628	peroxisome proliferator-activated receptor-gamma	Gene	5468
30405366	1630	1639	PPARgamma	Gene	5468
30405366	1641	1645	THCA	Chemical	-
30405366	1648	1654	5-HT1A	Gene	3350
30405366	1656	1659	CBD	Chemical	MESH:D002185
30405366	1661	1665	CBDA	Chemical	MESH:C006884
30405366	Negative_Correlation	MESH:D002185	MESH:D000070642
30405366	Negative_Correlation	MESH:C006884	MESH:D001932
30405366	Negative_Correlation	MESH:D013759	MESH:D000544
30405366	Association	MESH:C006884	3350
30405366	Negative_Correlation	MESH:D013729	MESH:D004827
30405366	Negative_Correlation	MESH:D002185	MESH:D000544
30405366	Association	MESH:D063388	5468
30405366	Negative_Correlation	MESH:D002185	MESH:D010300
30405366	Association	MESH:D063388	1269
30405366	Negative_Correlation	MESH:C006884	MESH:D000070627
30405366	Negative_Correlation	MESH:C006884	MESH:D000544
30405366	Association	MESH:D063388	3350
30405366	Negative_Correlation	MESH:D002185	MESH:D000070627
30405366	Association	MESH:C024714	MESH:D063388
30405366	Association	MESH:D063388	1268
30405366	Negative_Correlation	MESH:D002185	MESH:D004827
30405366	Negative_Correlation	MESH:C006884	MESH:D000070642
30405366	Negative_Correlation	MESH:C006884	MESH:D010300

